Muhammad Talha

Muhammad Talha

Auto-generated profile, based on publicly available information

Muhammad Talha

King Edward Medical University, Lahore, Pakistan

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
SSSemil Saleem
Semil Saleem
MTMuhammad Talha
Muhammad Talha
MFMahnoor Fatima
Mahnoor Fatima
FKFahad Khan
Fahad Khan
AIAbdullah Imtiaz
Abdullah Imtiaz

13 August 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FAFahad Amin
Fahad Amin
HKHira Khalid
Hira Khalid
MKMaliha Khalid
Maliha Khalid
MTMuhammad Talha
Muhammad Talha
AWAminath Waafira
Aminath Waafira
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare, rapidly progressive malignancy-related pulmonary vascular condition that remains difficult to diagnose before death due to its nonspecific clinical and imaging features. Recent advances in metabolomics, particularly when powered by artificial intelligence (AI), offer promising opportunities for early detection by identifying distinct metabolic signatures. While AI-driven metabolomics has shown success in various cancers, its application to PTTM is challenged by the rarity of the disease, limited datasets, and privacy concerns. Innovations such as multicenter collaborations and blockchain-based data sharing may help overcome these barriers. Integrating AI and metabolomics has the potential to revolutionize not only the diagnosis of PTTM but also other rare diseases with elusive early biomarkers.

22 November 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
FRFakiha Rahman
Fakiha Rahman
ARAmna Rahman
Amna Rahman
MTMuhammad Talha
Muhammad Talha
NNNoor Un Nisa
Noor Un Nisa
SISakan Binte Imran
Sakan Binte Imran

9 August 2025 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
MSMuhammad Huzaifa Sabir
Muhammad Huzaifa Sabir
MJMuhammad Nouman Javed
Muhammad Nouman Javed
MOMuhammad Owais
Muhammad Owais
MTMuhammad Talha
Muhammad Talha

28 August 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
ARAmna Rahman
Amna Rahman
MFMuneeb Faiz
Muneeb Faiz
MKMaliha Khalid
Maliha Khalid
MTMuhammad Talha
Muhammad Talha
AWAminath Waafira
Aminath Waafira
Myoclonic epilepsy with ragged-red fibers (MERRF) is a rare mitochondrial disorder primarily driven by mutations in mitochondrial DNA, particularly the m.8344A>G variant in MT-TK, and is characterized by epilepsy, myoclonus, ataxia, and other multisystemic features. With no curative therapy, recent attention has turned to the gut microbiome as a modifiable factor influencing neurologic symptoms in mitochondrial diseases. Dysbiosis—induced by antibiotics, diet, or preservatives—has been linked to altered microbial metabolites such as short-chain fatty acids and indoxyl sulfate, which may exacerbate neurological dysfunction. Preliminary clinical trials and preclinical studies suggest that probiotics and dietary interventions can modestly improve disease burden and symptoms such as constipation. However, significant challenges remain, including lack of standardization in analytical protocols, heterogeneous host-microbiota responses, and inadequate patient stratification. To fully realize the therapeutic potential of microbiome-based approaches in MERRF, coordinated multicenter trials, clear regulatory guidelines, and machine learning-enhanced stratification will be essential.

17 October 2025 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
KTKinza Tanveer
Kinza Tanveer
MTMuhammad Talha
Muhammad Talha
ASAraj Naveed Siddiqui
Araj Naveed Siddiqui
HYHermann Yokolo
Hermann Yokolo